Literature DB >> 2081475

The role of SAMe in the treatment of liver disease.

R Williams1, C S Lieber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2081475     DOI： 10.2165/00003495-199000403-00002

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  3 in total

1.  Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease.

Authors:  G Vendemiale; E Altomare; T Trizio; C Le Grazie; C Di Padova; M T Salerno; V Carrieri; O Albano
Journal:  Scand J Gastroenterol       Date:  1989-05       Impact factor: 2.423

2.  Estrogen cholestasis. Membranes, metabolites, or receptors?

Authors:  M Vore
Journal:  Gastroenterology       Date:  1987-09       Impact factor: 22.682

3.  Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats.

Authors:  F Feo; R Pascale; R Garcea; L Daino; L Pirisi; S Frassetto; M E Ruggiu; C Di Padova; G Stramentinoli
Journal:  Toxicol Appl Pharmacol       Date:  1986-04       Impact factor: 4.219
  3 in total
  1 in total

1.  Dietary supplement S-adenosyl-L-methionine (AdoMet) effects on plasma homocysteine levels in healthy human subjects: a double-blind, placebo-controlled, randomized clinical trial.

Authors:  Michael A Thompson; Brent A Bauer; Laura L Loehrer; Stephen S Cha; Jayawant N Mandrekar; Amit Sood; Dietlind L Wahner-Roedler
Journal:  J Altern Complement Med       Date:  2009-05       Impact factor: 2.579
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.